Literature DB >> 26699091

Serum adiponectin is independently associated with the metabolic syndrome in Hong Kong, Chinese women with polycystic ovary syndrome.

Jennifer Ka Yee Ko1, Hang Wun Raymond Li1, Karen Siu Ling Lam2, Sidney Tam2,3, Vivian Chi Yan Lee1, Tracy Wing Yee Yeung1, Pak Chung Ho1, Ernest Hung Yu Ng1.   

Abstract

OBJECTIVE: To evaluate the association of serum adiponectin level with the metabolic syndrome in Chinese women with polycystic ovary syndrome (PCOS).
METHODS: This was a cross-sectional study carried out in Hong Kong Chinese women with PCOS at a university-affiliated tertiary hospital between January 2010 and January 2011. Clinical and biochemical parameters of the women were analysed. Prediction of the metabolic syndrome was determined by receiver-operator characteristic (ROC) curves, univariate and multivariate logistic regression analyses.
RESULTS: A total of 116 women diagnosed to have PCOS were analysed. The area under the ROC curve of adiponectin for the prediction of metabolic syndrome was 0.820, 95% confidence interval (CI) 0.737-0.886. Univariate binary logistic regression showed that testosterone, sex hormone-binding globulin (SHBG), free androgen index (FAI), waist circumference, body mass index (BMI), quantitative insulin-sensitivity check index (QUICKI), homeostasis model assessment of insulin resistance (HOMA-IR) and adiponectin were significantly associated with the metabolic syndrome. On multivariate logistic regression analysis, adiponectin (p =  0.020), HOMA-IR, age (p =  0.011) and BMI (p =  0.019) were independently associated with the metabolic syndrome, but not FAI (p =  0.256).
CONCLUSIONS: Serum adiponectin is independently associated with the metabolic syndrome in Chinese women with PCOS. Further longitudinal follow-up studies are needed to determine whether serum adiponectin adds to the prediction of long-term cardiometabolic morbidity conferred by age, BMI and measures of insulin resistance.

Entities:  

Keywords:  Adiponectin; metabolic syndrome; polycystic ovary syndrome

Mesh:

Substances:

Year:  2015        PMID: 26699091     DOI: 10.3109/09513590.2015.1126708

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  5 in total

1.  Serum Anti-Müllerian Hormone in Polycystic Ovary Syndrome and its Relationship with Insulin Resistance, Lipid Profile and Adiponectin.

Authors:  Thien Jun Jun; Aniza Mohammed Jelani; Julia Omar; Rahimah Abdul Rahim; Najib Majdi Yaacob
Journal:  Indian J Endocrinol Metab       Date:  2020-04-30

2.  Serum ZAG and Adiponectin Levels Were Closely Related to Obesity and the Metabolically Abnormal Phenotype in Chinese Population.

Authors:  Meijuan Liu; Kun Zhang; Linjie Wang; Hongbo Yang; Kemin Yan; Hui Pan; Huijuan Zhu; Fengying Gong
Journal:  Diabetes Metab Syndr Obes       Date:  2020-08-26       Impact factor: 3.168

3.  Effects of oral contraceptives on serum concentrations of adipokines and adiposity indices of women with polycystic ovary syndrome: a randomized controlled trial.

Authors:  M Amiri; M Rahmati; M Hedayati; F Nahidi; F Ramezani Tehrani
Journal:  J Endocrinol Invest       Date:  2020-07-17       Impact factor: 4.256

4.  Clinical and Biochemical Characteristics in PCOS Women With Menstrual Abnormalities.

Authors:  Vasiliki Christodoulopoulou; Eftihios Trakakis; Vasilios Pergialiotis; Melpomeni Peppa; Charalampos Chrelias; Dimitrios Kassanos; Nikolaos Papantoniou
Journal:  J Family Reprod Health       Date:  2016-12

5.  Localization of adaptive variants in human genomes using averaged one-dependence estimation.

Authors:  Lauren Alpert Sugden; Elizabeth G Atkinson; Annie P Fischer; Stephen Rong; Brenna M Henn; Sohini Ramachandran
Journal:  Nat Commun       Date:  2018-02-19       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.